Stock Market Opens Flat: BEL, Tata Steel, HCL Tech in Focus
Indian stock markets opened flat on January 8, 2026, amid mixed global cues. Key stocks like BEL, Tata Steel, HCL Tech, Sun Pharma, Maruti, and TCS are in focus. Read the full analysis.
Category : Search result: Metformin HCL
IT Q3 Results: TCS, Infosys, HCL Tech Report Next Week
Indian IT giants TCS, Infosys, and HCL Tech announce Q3 results next week. Analysts eye end to weak earnings streak, focus on AI trends and management commentary. Key picks inside.
Metformin: Diabetes Drug's Potential in Cancer Prevention
New research explores metformin's potential link to reduced cancer risk in diabetes patients. Discover the facts, mechanisms, and crucial cautions.
Diabetes Medications May Influence Cancer Growth, Study Finds
New research explores how common diabetes drugs like metformin and GLP-1 agonists could impact cancer progression through immune function and inflammation. Learn about the potential implications.
5 IT Stocks Paying Large Dividends: Should You Invest?
Analysis of five IT stocks with high dividend yields: TCS, HCL Tech, Oracle Financial, Accelya, and Expleo. We examine their financials, prospects, and key risks for investors in 2026.
Metformin, PPIs Can Lead to Vitamin B12 Deficiency
Dr. Sudhir Kumar reveals how long-term use of Metformin and acid reflux drugs can deplete B12, leading to nerve damage. Learn the symptoms and how to stay safe.
IT Q3 FY25 Results: TCS, HCL Tech, Infosys Dates Announced
India's IT earnings season for Q3 FY25 starts in Jan 2026 with TCS & HCL Tech. Analysts see sector turnaround potential. Read expert picks for 2026.
Short-Term Stock Picks: HCL Tech, Britannia, Manappuram
Market expert Ajit Mishra of Religare Broking recommends three stocks for 1-2 weeks. Get technical analysis and target prices for HCL Tech, Britannia, and Manappuram Finance.
HCL's Roshni Nadar Malhotra meets CM Yogi, discusses UP plans
HCL Technologies Chairperson Roshni Nadar Malhotra met Uttar Pradesh CM Yogi Adityanath, discussing a new semiconductor unit with Foxconn and major expansion in Lucknow. UP emerges as a top tech hub.
Nuvama Cuts Voltas Target, Kotak Adds SBI Cards, CLSA Outperforms Dalmia
Key analyst calls on Indian stocks: Voltas faces weak demand, SBI Cards asset quality improves, Dalmia sees volume growth, HCL Tech's acquisition, and Divis Labs' US Act impact. Get the full market insight.
UP's First Semiconductor Unit by HCL-Foxconn in Jan 2026
HCL and Foxconn's joint venture in Jewar will build India's crucial OSAT unit for display driver chips, cutting imports. Groundbreaking set for January 2026. Read more.
Stocks in Focus: SBI, Tata Power, HCL Tech, Indian Hotels
Key stocks including SBI, Tata Power, HCL Technologies, Indian Hotels, and Texmaco Rail are on investors' radar today. Get the latest analysis and market-moving news.
Top Stock Picks for Dec 2: Ashok Leyland, HCL Tech, BoB
Mirae Asset Sharekhan's Somil Mehta recommends buying Ashok Leyland, HCL Tech, and Bank of Baroda on December 2. Check key price levels, targets, and technical analysis.
India's Top 10 IT Companies by Market Cap in 2025
Discover the top 10 Indian IT companies by market cap in 2025. TCS leads the ranking with a massive Rs 11.25 lakh crore valuation, followed by Infosys and HCL Tech. Explore the list now!
Stock Market Negative Start: IT Stocks Drag Markets
Indian stock markets opened negative on November 25 with GIFT Nifty signaling weak global cues. IT stocks including Infosys and HCL Tech under pressure. Asian markets mixed.
HCL Recruitment 2025: 64 Junior Manager Jobs
Hindustan Copper Limited (HCL) invites applications for 64 Junior Manager posts. Apply online from Nov 27 to Dec 17, 2025. Check eligibility, salary, and selection process.
HCL Foundation Expands Support for Indian Para-Athletes
HCL Foundation announces comprehensive support program for Indian para-athletes, including financial aid, equipment support, and training facilities. Discover how this initiative transforms para-sports in India.
Granules India Gets USFDA Approval for Hyderabad Plant
Granules Life Sciences receives USFDA approval for new Hyderabad facility to manufacture diabetes drug Metformin HCL. Capacity: 10 billion tablets annually. Read more about this pharmaceutical milestone.
HCL Co-founder: Tech Weapons in Global Trade - India Alert
Ajai Chowdhry, HCL Technologies co-founder, warns that advanced technologies are being weaponized in international trade wars. Discover why India needs urgent strategic response to protect its technological sovereignty and economic future.
HCL Co-founder: Ban Chinese Chips Over Security Risks
Ajai Chowdhary warns of critical security threats from imported Chinese semiconductors and calls for immediate government action to protect national data.
Indian IT Giants Missing AI Revolution: Bessemer VC
Bessemer Venture Partners reveals why Indian IT majors are losing the AI race and how nimble startups are poised to dominate the $5 trillion AI opportunity in India.
Diabetes & Liver Drugs May Boost Brain Health: Study
Groundbreaking research reveals two existing medications - diabetes drug metformin and liver disease treatment ursodeoxycholic acid - could significantly enhance brain function and protect against cognitive decline.
Noida's ₹4.5Cr Smart Road Makeover in Sector 126
Noida Authority transforms Sector 126 with a 500-meter model road featuring smart infrastructure, green spaces, and vendor zones. HCL office connectivity enhanced.
Stock Market: GIFT Nifty Up, IT Stocks in Focus Today
Indian markets poised for optimistic opening as GIFT Nifty trends upward. Infosys, HCL Tech, Maruti, and Power Grid in focus amid falling gold prices and mixed global signals. Get expert analysis on today's trading strategy.
Indian IT Giants Bet Big on AI: $6-8B Strategy Revealed
Discover how India's top 5 IT services companies are investing billions in generative AI, reshaping their business models, and competing for $6-8 billion in new contracts as artificial intelligence transforms the industry.
Infosys vs TCS vs Wipro vs HCL: Q2 Stock Analysis
Exclusive analysis of India's top 4 IT stocks after Q2 FY2025 results. Discover which company delivered the strongest performance and which stock analysts are betting on for maximum returns.
Page 1 of 1